CFD'er er komplekse instrumenter, og der er stor risiko for at miste penge hurtigt på grund af gearing. 84% af individuelle investorer taber penge, når de handler CFD'er med denne udbyder. Du bør overveje, om du forstår, hvordan CFD'er virker, og om du har råd til at løbe en høj risiko for at miste dine penge.

Handel Ionis Pharmaceuticals, Inc. - IONS CFD

41.71
2.86%
0.17
Lav: 41.13
Høj: 42.97
Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Fri: 13:30 - 20:00

  • Opsummering
  • Historisk Data
  • Begivenheder
  • Resultatopgørelse
  • Saldo
  • Cash flow
  • Ejerskab
Handelsbetingelser
Spænd 0.17
Long position, gebyr natten over

Long position overnight fee


Margin. Your investment $1,000.00
Gebyr for natten over -0.025457 %
Charges from borrowed part ($-1.02)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Gå til platform
-0.025457%
Short position, gebyr natten over

Short position overnight fee


Margin. Your investment $1,000.00
Gebyr for natten over 0.003235 %
Charges from borrowed part ($0.13)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Gå til platform
0.003235%
Gebyr natten over, tid 21:00 (UTC)
Min. handlet mængde 1
Valuta USD
Margen 20%
Aktiebørs United States of America
Kommission på handel 0%

*Information provided by Capital.com

Ionis Pharmaceuticals Inc ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

Nøglestatistikker
Tidligere luk* 42.94
Åben* 42.97
1-Års Ændring* 19.76%
Dagens Spænd* 41.13 - 42.97
52-Ugers Spænd 32.69-48.82
Gennemsnitlig Volumen (10 dage) 1.48M
Gennemsnitlig Volumen (3 måneder) 21.22M
Market Cap 5.97B
P/E-forhold -100.00K
Udestående aktier 143.09M
Omsætning 575.97M
EPS -2.31
Dividend (Udbytte %) N/A
Beta 0.52
Næste indtjeningsopgørelse Aug 7, 2023

Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Luk Change Change (%) Åben High Low
Jun 2, 2023 41.71 0.52 1.26% 41.19 43.27 41.08
Jun 1, 2023 42.94 3.49 8.85% 39.45 43.03 39.45
May 31, 2023 40.73 0.71 1.77% 40.02 41.21 39.74
May 30, 2023 40.51 0.26 0.65% 40.25 41.55 39.84
May 26, 2023 40.60 2.27 5.92% 38.33 40.83 38.33
May 25, 2023 39.13 -0.39 -0.99% 39.52 41.57 38.89
May 24, 2023 41.24 -0.58 -1.39% 41.82 42.47 41.09
May 23, 2023 42.16 1.62 4.00% 40.54 43.42 40.54
May 22, 2023 40.61 1.75 4.50% 38.86 40.81 37.78
May 19, 2023 39.02 3.61 10.19% 35.41 39.31 35.41
May 18, 2023 36.58 2.03 5.88% 34.55 36.70 34.55
May 17, 2023 36.13 1.42 4.09% 34.71 36.29 34.70
May 16, 2023 35.79 0.93 2.67% 34.86 35.96 34.81
May 15, 2023 36.09 0.68 1.92% 35.41 36.39 34.70
May 12, 2023 35.38 0.05 0.14% 35.33 35.68 35.16
May 11, 2023 35.48 0.79 2.28% 34.69 35.72 34.69
May 10, 2023 35.69 0.86 2.47% 34.83 36.65 34.83
May 9, 2023 35.57 0.81 2.33% 34.76 36.18 34.51
May 8, 2023 35.18 -0.28 -0.79% 35.46 35.88 34.81
May 5, 2023 36.06 0.94 2.68% 35.12 36.55 34.80

Ionis Pharmaceuticals, Inc. Events

Tid (UTC) (UTC) Land Begivenhed
Monday, June 12, 2023

Tid (UTC) (UTC)

16:20

Land

US

Begivenhed

Ionis Pharmaceuticals Inc at Goldman Sachs Healthcare Conference
Ionis Pharmaceuticals Inc at Goldman Sachs Healthcare Conference

Forecast

-

Previous

-
Monday, August 7, 2023

Tid (UTC) (UTC)

12:30

Land

US

Begivenhed

Q2 2023 Ionis Pharmaceuticals Inc Earnings Release
Q2 2023 Ionis Pharmaceuticals Inc Earnings Release

Forecast

-

Previous

-
Tuesday, November 7, 2023

Tid (UTC) (UTC)

13:30

Land

US

Begivenhed

Q3 2023 Ionis Pharmaceuticals Inc Earnings Release
Q3 2023 Ionis Pharmaceuticals Inc Earnings Release

Forecast

-

Previous

-
Se alle begivenheder
  • Årlig
  • Pr kvartal
2022 2021 2020 2019 2018
Total omsætning 587.367 810.456 729.264 1122.6 599.674
Omsætning 587.367 810.456 729.264 1122.6 599.674
Kost af omsætning, Total 14.116 10.842 11.947 4.384 1.82
Bruttofortjeneste 573.251 799.614 717.317 1118.21 597.854
Totale Driftsudgifter 997.558 849.269 901.346 822.912 661.046
Salgs/Generelle/Admin. Udgifter, Total 150.295 170.947 332.222 286.644 244.622
Forskning & Udvikling 833.147 634.953 526.877 465.688 414.604
Usædvanlig Udgift (Indkomst) 32.527 30.3 66.196 0
Driftsindtægter -410.191 -38.813 -172.082 299.687 -61.372
Renteindkomst (Udgift), Netto Ikke-Drift 9.876 10.798 37.592 39.765 -14.602
Andre, Netto -7.274 -1.133 -0.062 -0.686 -0.182
Netto Indkomst Før Skat -257.985 -29.148 -134.552 338.766 -76.156
Netto Indkomst Efter Skat -269.722 -28.597 -479.743 287.259 -117.115
Minoritetsrente 0 0 35.48 -9.116 58.756
Netto Indkomst Før Ekstra Ting -269.722 -28.597 -444.263 278.143 -58.359
Netto Indkomst -269.722 -28.597 -444.263 278.143 273.741
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -269.722 -28.597 -444.263 278.143 -58.359
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -269.722 -28.597 -444.263 278.143 273.741
Fortyndelsesændring 0
Fortyndet Netto Indkomst -269.722 -28.597 -444.263 278.143 273.741
Fortyndet Vægtet Gennemsnit Aktier 141.848 141.021 139.612 153.164 134.056
Fortyndet EPS Uden Ekstraordinære Ting -1.90149 -0.20279 -3.18213 1.81598 -0.43533
Fortyndet Normaliseret EPS -2.58703 -0.05286 -3.04106 2.18246 -0.43533
Totale Ekstraordinære Ting 332.1
Gain (Loss) on Sale of Assets 149.604
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total omsætning 130.524 151.889 159.767 133.791 141.919
Omsætning 130.524 151.889 159.767 133.791 141.919
Kost af omsætning, Total 1.343 3.686 1.515 4.745 4.17
Bruttofortjeneste 129.181 148.203 158.252 129.046 137.749
Totale Driftsudgifter 244.672 359.908 218.921 219.305 199.423
Salgs/Generelle/Admin. Udgifter, Total 45.516 47.95 34.416 33.802 34.127
Forskning & Udvikling 197.813 308.272 182.99 180.758 161.126
Driftsindtægter -114.148 -208.019 -59.154 -85.514 -57.504
Renteindkomst (Udgift), Netto Ikke-Drift 16.49 13.436 7.732 -5.064 -6.754
Andre, Netto -15.285 0.649 4.713 -12.297 0.187
Netto Indkomst Før Skat -112.943 -44.33 -46.709 -102.875 -64.071
Netto Indkomst Efter Skat -124.323 -52.43 -46.992 -105.135 -65.165
Minoritetsrente 0
Netto Indkomst Før Ekstra Ting -124.323 -52.43 -46.992 -105.135 -65.165
Netto Indkomst -124.323 -52.43 -46.992 -105.135 -65.165
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -124.323 -52.43 -46.992 -105.135 -65.165
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -124.323 -52.43 -46.992 -105.135 -65.165
Fortyndet Netto Indkomst -124.323 -52.43 -46.992 -105.135 -65.165
Fortyndet Vægtet Gennemsnit Aktier 142.735 142.046 141.95 141.794 141.599
Fortyndet EPS Uden Ekstraordinære Ting -0.87101 -0.36911 -0.33105 -0.74146 -0.46021
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Fortyndet Normaliseret EPS -0.87101 -1.05369 -0.33105 -0.74146 -0.46021
Usædvanlig Udgift (Indkomst)
Gain (Loss) on Sale of Assets 149.604
  • Årlig
  • Pr kvartal
2022 2021 2020 2019 2018
Totale Nuværende Aktiver 2202.69 2345.05 2130.71 2720.6 2207.89
Likvider og Kortsigtede Investeringer 1986.87 2114.97 1892.38 2499.54 2084.07
Likvider & Lignende 276.472 869.191 397.664 683.287 278.82
Kortsigtede Investeringer 1710.4 1245.78 1494.71 1816.26 1805.25
Totale Tilgodehavender, Netto 25.538 61.896 76.204 63.034 12.759
Accounts Receivable - Trade, Net 25.538 61.896 76.204 63.034 12.759
Total Inventory 22.033 24.806 21.965 18.18 8.582
Other Current Assets, Total 168.254 143.374 140.163 139.839 102.473
Total Assets 2533.88 2611.69 2389.75 3233.11 2667.78
Property/Plant/Equipment, Total - Net 255.838 196.069 181.077 166.251 132.16
Property/Plant/Equipment, Total - Gross 343.554 298.722 240.264 193.634
Accumulated Depreciation, Total -87.716 -102.653 -74.013 -61.474
Intangibles, Net 29.005 27.937 25.674 24.032
Other Long Term Assets, Total 75.344 41.567 50.034 320.59 303.706
Total Current Liabilities 311.561 240.55 598.898 273.005 280.294
Accounts Payable 17.921 11.904 17.199 16.067 28.66
Accrued Expenses 196.494 129.97 155.889 106.152 77.629
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.32 0.926 316.11 13.749
Other Current Liabilities, Total 96.826 97.75 109.7 150.786 160.256
Total Liabilities 1960.99 1839.95 1646.47 1762.02 1619.7
Total Long Term Debt 1182.72 1228.02 623.529 770.3 632.971
Long Term Debt 1182.72 1228.02 623.529 770.3 632.971
Capital Lease Obligations
Other Liabilities, Total 466.709 371.379 424.046 505.26 567.359
Total Equity 572.887 771.737 743.282 1471.09 1048.08
Common Stock 0.142 0.141 0.14 0.14 0.138
Additional Paid-In Capital 2059.85 1964.17 1895.52 2203.78 2047.25
Retained Earnings (Accumulated Deficit) -1429.62 -1159.9 -1131.31 -707.534 -967.293
Other Equity, Total -57.48 -32.668 -21.071 -25.29 -32.016
Total Liabilities & Shareholders’ Equity 2533.88 2611.69 2389.75 3233.11 2667.78
Total Common Shares Outstanding 142.058 141.21 140.366 140.34 137.929
Minority Interest 213.453 139.081
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Totale Nuværende Aktiver 2542.62 2202.69 2152.13 2191.15 2253.12
Likvider og Kortsigtede Investeringer 2346.78 1986.87 1981.66 2021.83 2052.39
Likvider & Lignende 309.031 276.472 314.993 521.917 542.513
Kortsigtede Investeringer 2037.75 1710.4 1666.67 1499.91 1509.88
Totale Tilgodehavender, Netto 13.914 25.538 6.645 6.751 26.122
Accounts Receivable - Trade, Net 13.914 25.538 6.645 6.751 26.122
Total Inventory 22.2 22.033 20.645 19.811 24.032
Other Current Assets, Total 159.724 168.254 143.173 142.759 150.577
Total Assets 2885.22 2533.88 2421.97 2456.13 2519.09
Property/Plant/Equipment, Total - Net 264.306 255.838 180.806 177.015 177.724
Intangibles, Net 29.605 29.054 29.295
Other Long Term Assets, Total 78.296 75.344 59.434 58.916 58.949
Total Current Liabilities 259.221 311.561 283.454 267.811 228.45
Accounts Payable 10.499 17.921 20.545 10.351 16.125
Accrued Expenses 130.862 189.279 158.412 159.321 115.781
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 8.239 7.535 4.97 4.732 4.206
Other Current Liabilities, Total 109.621 96.826 99.527 93.407 92.338
Total Liabilities 2398.65 1960.99 1827.61 1831.41 1809.52
Total Long Term Debt 1184.38 1182.72 1249.5 1248.4 1247.93
Long Term Debt 1184.38 1182.72 1249.5 1248.4 1247.93
Other Liabilities, Total 955.054 466.709 294.656 315.196 333.138
Total Equity 486.57 572.887 594.361 624.726 709.574
Common Stock 0.143 0.142 0.142 0.142 0.142
Additional Paid-In Capital 2089.36 2059.85 2034.55 2008.79 1983.08
Retained Earnings (Accumulated Deficit) -1553.95 -1429.62 -1377.19 -1330.2 -1225.07
Other Equity, Total -48.983 -57.48 -63.14 -54.007 -48.578
Total Liabilities & Shareholders’ Equity 2885.22 2533.88 2421.97 2456.13 2519.09
Total Common Shares Outstanding 143.023 142.058 142.017 141.831 141.753
  • Årlig
  • Pr kvartal
2022 2021 2020 2019 2018
Netto indkomst/Startlinje -269.722 -28.597 -479.743 287.259 214.985
Likvider Fra Driftsaktiviteter -274.37 30.799 35.892 345.627 602.906
Likvider Fra Driftsaktiviteter 14.328 15.487 13.365 12.54 10.706
Amortization 2.415 2.352 2.064 1.912 1.822
Deferred Taxes 0 0 341.729 0.911 -290.516
Ikke-Likvide Ting -28.962 155.375 232.032 211.806 166.484
Likvid Rente Betalt 2.898 4.778 6.247 9.87 9.592
Ændringer i Driftskapital 7.571 -113.818 -73.555 -168.801 499.425
Likvider fra Investeringsaktiviteter -262.636 194.906 274.477 -41.274 -929.563
Kapitaludgifter -15.721 -11.955 -35.12 -30.905 -13.608
Andre Investerings-Cash-Flow-Ting, Total -246.915 206.861 309.597 -10.369 -915.955
Likvider fra Financieringsaktiviteter -55.295 245.933 -596.609 100.021 475.865
Financiering af Cash-Flow-Ting -10.982 -168.954 -558.097 -138.354 0
Udstedelse (Pensionering) af Aktier, Netto 6.373 101.317 -38.512 141.375 475.865
Udstedelse (Pensionering) af Gæld, Netto -50.686 313.57 0 97 0
Netto Ændring i Likviditet -592.719 471.527 -285.623 404.467 149.19
Cash Taxes Paid 5.01 0.038 25.855 9.041 0
Udenlandsk Børs Effekter -0.418 -0.111 0.617 0.093 -0.018
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -124.323 -269.722 -217.292 -170.3 -65.165
Cash From Operating Activities -133.992 -274.37 -74.175 -49.746 -31.65
Cash From Operating Activities 2.604 14.328 11.301 7.484 3.701
Amortization 0.607 2.415 1.805 1.197 0.592
Deferred Taxes 0
Non-Cash Items 42.124 -28.962 91.563 64.125 32.983
Cash Taxes Paid 0.293 5.01 0.002 0.002 0.002
Cash Interest Paid 0.089 2.898 2.204 1.544 0.594
Changes in Working Capital -55.004 7.571 38.448 47.748 -3.761
Cash From Investing Activities -325.64 -262.636 -474.783 -290.853 -287.549
Capital Expenditures -10.472 -15.721 -11.582 -6.04 -2.705
Other Investing Cash Flow Items, Total -315.168 -246.915 -463.201 -284.813 -284.844
Cash From Financing Activities 492.087 -55.295 -4.276 -6.11 -7.325
Financing Cash Flow Items 489.566 -10.982 -10.217 -9.572 -9.173
Issuance (Retirement) of Stock, Net 2.56 6.373 6.03 3.462 1.848
Foreign Exchange Effects 0.104 -0.418 -0.964 -0.565 -0.154
Net Change in Cash 32.559 -592.719 -554.198 -347.274 -326.678
Issuance (Retirement) of Debt, Net -0.039 -50.686 -0.089 0
Investornavn Investortype Procent udestående Aktiebeholdning Aktieændring Beholdningsdato IOmsætningsscore
Fidelity Management & Research Company LLC Investment Advisor 14.9808 21436334 128815 2023-03-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 9.7482 13948885 429096 2023-03-31 LOW
T. Rowe Price Investment Management, Inc. Investment Advisor 9.1298 13064047 1385788 2023-03-31 MED
Bellevue Asset Management AG Investment Advisor 6.6474 9511900 -232000 2023-03-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 4.9323 7057705 -70015 2023-03-31 LOW
ClearBridge Investments, LLC Investment Advisor/Hedge Fund 3.7679 5391581 -34061 2023-03-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 2.8432 4068334 -150395 2023-03-31 LOW
T. Rowe Price Associates, Inc. Investment Advisor 2.6508 3793044 -359563 2023-03-31 LOW
Tweedy, Browne Company LLC Investment Advisor 2.4747 3541046 -90 2023-03-31 LOW
Deep Track Capital LP Hedge Fund 1.9806 2834069 1628296 2023-03-31 HIGH
ARK Investment Management LLC Investment Advisor 1.843 2637192 -36346 2023-03-31 LOW
BVF Partners L.P. Hedge Fund 1.7896 2560761 1438952 2023-03-31 LOW
OrbiMed Advisors, LLC Investment Advisor/Hedge Fund 1.4847 2124500 130900 2023-03-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.4466 2069950 57227 2023-03-31 LOW
Camber Capital Management LP Hedge Fund 1.3453 1925000 0 2023-03-31 MED
First Trust Advisors L.P. Investment Advisor 1.1454 1638943 -141990 2023-03-31 LOW
Macquarie Investment Management Investment Advisor 1.044 1493903 2216 2023-03-31 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.9062 1296647 511086 2022-12-31 LOW
Charles Schwab Investment Management, Inc. Investment Advisor 0.8291 1186393 -69875 2023-03-31 LOW
Pictet Asset Management Ltd. Investment Advisor/Hedge Fund 0.7778 1113042 739456 2023-03-31 LOW

Hvorfor vælge Capital.com? Vores tal taler for sig selv.

Capital.com Group

535K+

Handlende

87K+

Månedlkige, aktive klienter

$113M+

Månedlig investeringsvolumen

$64M+

Hævet hver måned

Handelslommeregner

Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).

Handelskurtage
0
  • 1:1
Gearing
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investering
Handelsstørrelse (Gearing x Investering):
Åben

Luk

Short Long

Ionis Pharmaceuticals Company profile

Om Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc. beskæftiger sig med opdagelse og udvikling af ribonukleinsyre (RNA)-målrettede terapeutika. Selskabet er primært fokuseret på vores kardiovaskulære og neurologiske forretningsområder. Virksomhedens produkter omfatter SPINRAZA, TEGSEDI og WAYLIVRA. SPINRAZA er til behandling af patienter i alle aldre med spinal muskelatrofi (SMA), en progressiv, invaliderende og ofte dødelig genetisk sygdom. TEGSEDI er til behandling af patienter med polyneuropati forårsaget af arvelig transthyretin (TTR), amyloidose (hATTR), en invaliderende, progressiv og dødelig sygdom. WAYLIVRA er et antisense-medicin, der er indiceret som et supplement til diæt hos voksne patienter. Selskabet har over seks lægemidler i fase III-undersøgelser for otte indikationer, som omfatter Eplontersen (TTR), Olezarsen (ApoC-III), Donidalorsen (PKK), ION363 (FUS), Pelacarsen (Apo(a)) og Tofersen (SOD1). Dens kardiovaskulære lægemidler under udvikling omfatter Eplontersen, Olezarsen, Pelacarsen, ION449 (PCSK9), Fesomersen og IONIS-AGT-LRx.

Industry: Biotechnology & Medical Research (NEC)

2855 Gazelle Court
CARLSBAD
CALIFORNIA 92010
US

Resultatopgørelse

  • Annual
  • Quarterly

Folk ser også

Oil - Crude

71.98 Price
+2.450% 1D Chg, %
Long position, gebyr natten over -0.0201%
Short position, gebyr natten over -0.0018%
Gebyr natten over, tid 21:00 (UTC)
Spænd 0.04

Gold

1,948.36 Price
-1.480% 1D Chg, %
Long position, gebyr natten over -0.0185%
Short position, gebyr natten over 0.0103%
Gebyr natten over, tid 21:00 (UTC)
Spænd 0.30

BTC/USD

27,251.75 Price
+0.580% 1D Chg, %
Long position, gebyr natten over -0.0616%
Short position, gebyr natten over 0.0137%
Gebyr natten over, tid 21:00 (UTC)
Spænd 60.00

XRP/USD

0.54 Price
+3.390% 1D Chg, %
Long position, gebyr natten over -0.0753%
Short position, gebyr natten over 0.0069%
Gebyr natten over, tid 21:00 (UTC)
Spænd 0.00540

Leder du stadig efter en mægler, du kan stole på?

Deltag sammen med 535.000+ handlende over hele verden, der valgte at handle hos Capital.com

1. Opret og bekræft din konto 2. Lav en inddbetaling 3. Find din handel